We may look back on this in a few years and say, "Remember how we thought that was a big deal back then? Now, it's everywhere." The first cryptocurrency-backed conventional mortgage has been issued to a couple in Michigan.
If the future of finance is tokenization, this will be the first of many. Converting traditional real-world **** ets — such as currency, real estate, stocks, and bonds — into digital tokens on a blockchain is expected to reframe the world's financial infrastructure.
And the future began in June 2026.
Better and Coinbase have issued their first Fannie Mae-backed crypto mortgage to Joe and Amy of Ann Arbor, Michigan. When Joe first considered getting a mortgage and making a down payment with bitcoin, his options seemed limited.
"The two alternatives me and my wife were looking at was either selling and paying long-term cap gains or using a margin loan type structure, which is quite stressful because the interest rate is obviously very variable. And then there's also a margin call risk **** ociated with that, which is obviously scary," Joe told Yahoo Finance.

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best inexpensive stocks to invest in right now. Gilead Sciences, Inc. (NASDAQ:GILD) announced on May 27 new results from a post hoc ***** ysis that showed that Livdelzi® was ***** ociated with high and sustained rates of normalization of a key liver marker in people living with primary biliary cholangitis. The company reported that participants with increased ALP levels in an ongoing Phase 3 study experienced reductions in ALP after treatment, and the data showcase the potential role of Livdelzi in people with PBC who continually have elevated ALP despite prior treatment with first-line therapy.
Gilead Sciences, Inc. (NASDAQ:GILD) stated that the findings are “highly relevant” for people living with PBC with inadequately controlled disease based on elevated ALP levels, as that is a population that is historically underrepresented in randomized clinical trials. The company would present the data at the European ***** ociation for the Study of the Liver (EASL) Congress 2026, held May 27–30 in Barcelona, Spain.
Gilead Sciences, Inc. (NASDAQ:GILD) is a biotech company that advances medicines to prevent and treat serious diseases such as cancer, immunodeficiency virus (HIV), viral hepatitis, and COVID-19. Its portfolio of drugs focuses on medical areas with unmet needs and includes AmBisome, Atripla, Biktarvy, Cayston, Complera, and others.
While we acknowledge the potential of GILD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

With a market cap of $82.3 billion, HCA Healthcare, Inc. (HCA) is a leading healthcare services company in the United States that provides a broad range of medical services through its subsidiaries. The company owns, manages, and operates hospitals, ambulatory surgery centers, emergency care facilities, urgent care centers, clinics, and various outpatient healthcare services.
Companies valued at $10 billion or more are generally considered “large-cap” stocks, and HCA Healthcare fits this criterion perfectly. Its hospitals offer comprehensive inpatient and outpatient care, including surgical, diagnostic, cardiac, emergency, and rehabilitation services.
Dear Microsoft Stock Fans, Mark Your Calendars for June 2
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
Dell Stock Could Be Worth 30% More - Based on Strong AI Demand and FCF